Profil
Dr. Matthew Myntti is a President at Next Science Ltd. He is on the Board of Directors at Microbial Defense System Holdings, Inc. Dr. Myntti was previously employed as a President-Asia Pacific by Synthes GmbH.
He received his undergraduate degree from the University of Dayton and a doctorate degree from the University of Dayton.
Postes actifs de Matthew Myntti
| Sociétés | Poste | Début |
|---|---|---|
| NEXT SCIE | President | 01/05/2012 |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Provides investment advice | Directeur/Membre du Conseil | 30/03/2012 |
Anciens postes connus de Matthew Myntti
| Sociétés | Poste | Fin |
|---|---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery | Corporate Officer/Principal | - |
Formation de Matthew Myntti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery | Health Technology |
Next Science Ltd.
Next Science Ltd. BiotechnologyHealth Technology Engages in research, development and distribution of technologies for the treatment of biofilm based infections | Health Technology |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Provides investment advice | Finance |
















